Most of us deal with sick and injured workers on a daily basis. At some point, daily tasks and deadlines take over and empathy takes a backseat.
Read here.Wholesale prices fell for the second consecutive month in May and continued to fall into mid-June, as the less-than-impressive 2024 Spring/tax season market came to an early close. Nevertheless, wholesale and retail used vehicle market conditions are amenable to a less dramatic ongoing decline in prices than seen last year, as much of the correction to historical patterns of depreciation, seasonality and price-spread versus new vehicles has already taken place.
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dive deeper into part two of our annual drug trends series. In this short video they will discuss aggregate trends and challenges within our combined in- and out-of-network channels to address the total view of prescription activity.
Discover how early intervention telephonic case management (TCM) integrates clinical expertise, AI, and technology to enhance workers' compensation claims, promote faster recoveries, and build trust with injured employees.
Work-related injuries involving limb or other losses are rare but tragic for any individual and require sensitive care coordination. The complexity and high costs associated with prosthetics require detailed attention to ensure both the well-being of the injured employee and cost-effective management. Here are key insights and strategies to optimize outcomes in these sensitive cases:
Discover how partnering with a tailored telephonic case management (TCM) program can enhance return-to-work outcomes. Hear from Dawn Moore on assessing and customizing TCM programs to meet unique client needs in this insightful podcast episode.
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dig into part one of our annual drug trends series. In this short video they’ll discuss standout trends from our most recent retail and mail order data focusing on decreasing opioid trends and significant jumps in migraine and respiratory medications.